COVID-19

Our Advantages

ZiP Diagnostics is bringing a sensitivity molecular test for SARS-CoV-2,

to domestic high-volume production.

The ZiP-CoVx test is a point-of-care molecular diagnostic technology that combines its test instruments and assay (swab and cartridge with reagents) manufacturing capacity.

The advantages of this system include:

Direct detection of current SARS-CoV-2 viral infection (not an antibody test).

​

Sample type includes nasal, nasal-pharyngeal or throat swab with direct insertion into sealed cartridge (saliva sample type in development).  

​

Test result within 15 to 30 minutes with high sensitivity comparable to PCR.

​

True point-of-care, quickly deploy testing to any location to maximise impact on COVID-19 identification and management.

​

Low  cost test, significantly less than existing laboratory tests (order volume dependant).

​

Individual test and high throughput cartridge and instrument configurations available.

Site management software provides secure, encrypted records and management of workflow, site administration, sample collection and test instruments.

​

​

​

​